Svend Andersen - Perrigo Company President

PRGO -- USA Stock  

USD 46.18  0.51  1.12%

  President
Mr. Svend Andersen is Executive Vice President, President Consumer Healthcare International of the Company
Age: 56  President Since 2017      
353 1 709 4000  http://www.perrigo.com
Andersen Prior to joining Perrigo in May 2016, Mr. Andersen served as Executive Vice President Europe for LEOPharma from December 2015 to May 2016. Prior to that, he was Regional President and Corporationrationrationrate officer at Hospira, Inc.?s Europe, Middle East and Africa business for five years, was Executive Vice President responsible for the Western European division?s pharmaceuticals, generics, OTC and hospital products businesses at Actavis from 2008 to 2015 including leading Alpharma?s EMEA businesses prior to its acquisition by Actavis, and prior to that, spent 10 years with Ferrosan specialized in OTC and consumer health products as Vice President for Global Commercial Operations.

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives

PRESIDENT Since

Roman TrawickiZoetis
2015
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Catherine KnuppZoetis
2012
K RaoDr Reddys Laboratories Ltd
2016
Joyce LeeZoetis
2012
Michael PariniVertex Pharmaceuticals Incorpor
2017
J RamachandranDr Reddys Laboratories Ltd
2016
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
George YancopoulosRegeneron Pharmaceuticals
2016
Christopher FenimoreRegeneron Pharmaceuticals
2017
Joseph LaRosaRegeneron Pharmaceuticals
2019
Alok SonigDr Reddys Laboratories Ltd
2015
Raghav ChariDr Reddys Laboratories Ltd
2013
Ian SmithVertex Pharmaceuticals Incorpor
2017
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Roxanne LaganoZoetis
2015
Daniel PlewRegeneron Pharmaceuticals
2016
Kristin PeckZoetis
2018
Samiran DasDr Reddys Laboratories Ltd
2016
Peter PowchikRegeneron Pharmaceuticals
2006
Ganadhish KamatDr Reddys Laboratories Ltd
2016

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Currently Active Assets on Macroaxis

MA   
Purchased over 30 shares of
a day ago
Traded for 267.15
V   
Purchased over 50 shares of
a day ago
Traded for 173.51
EVER   
Purchased over 500 shares of
a day ago
Traded for 21.29
AMZN   
Purchased one share of
a day ago
Traded for 1792.5699
AU   
Purchased over 90 shares of
a day ago
Traded for 1.84
Additionally take a look at Your Equity Center. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Search macroaxis.com